Stem cells, tissue cultures and the production of biovalue

This article examines some of the social and philosophical implications of stem cell technologies. Stem cell technologies promise to transform the way that healthy tissues for transplant are sourced and circulated; from a social economy in which citizens donate whole organs to others, to one in which embryos are a major source of therapeutic tissues. This article considers the transformations in concepts of health, bodily relationships and social indebtedness that such a shift might entail. Using the concept of biovalue, this article describes the ways embryos are biologically engineered to act as tissue sources, and considers the relationship between biovalue, health and capital value. It discusses the effects stem cell technologies may have on concepts of the healthy body, particularly on the temporality of ageing, and on understandings of the human more generally.